551
184194226014562116179
Ces8507936014570127174
Urol10497936014578115180208
2022;12827936014562121178238261
26(3):15687936014562120153211240262
174–18518557936014562113165228281336395
PŘEHLEDOVÉ852207016974156235334409485586692777855
ČLÁNKY1746207016989162260360444533
13.850896013356104125
Hildebrandt99889601336792117178233294330382442503538
B,155989601335678
Wust1660896013388146188224
P,190789601335564
Ahlers1994896013363123147202237280
O,229789601337291
et241189601335187
al.25218960133497496
The2641898013147106159
cellular282389801314595118139195217265296
and3143898013145102161
molecular3328898013186143166218267324346394424
basis3776898013157106145166205
of400489801315583
hyperthermia4110898013155100161214245282339391422511533580
Crit473289801315989111144
Rev4900898013151104152
Oncol5076898013169127175231253
Hematol8501048013169122211260293349372
2002;12641048013154105160210227
43(1):15151048013154103130177197214
33–5617531048013154103159210262
14.8501196013356104126
Haveman9991196013367119168221311362422
J,1443119601333757
Smals15231196013350139190215256
OA,18021196013371134158
Rodermond19831196013354114175229264354413473534
HM.25401196013367154177
Effects2741119801314674103154203238279
of3043119801315482
hyperthermia31481198013155100159212243279336388419508529576
on37471198013154112
the3882119801313087139
rat4044119801312877109
bladder:4176119801315679126185243295326345
a45441198013145
pre‑clinical4613119801315687138172223244265321342390438460
study5096119801313771127186233
on8501348013159117
thermometry991134801313492145177267325415468501533584
and15991348013150108168
functional1791134801312987145194230252310368417439
damage22541348013160109198247306359
after2637134801315078116167198
treatment2859134801313466117165198287340398430
Int3332134801312381113
J34691348013138
Hyperthermia35311348013169117178232263300359412443533555603
2003;41771348013154105160210226
19:4427134801315499118
45–5745691348013153103158209260
15.8501496013356105126
Oei9991496013379135160
AL,11821496013370121145
Kok13501496013363121173
HP,15461496013374133142
Oei17121496013378134159
SB,18951496013357115137
et2056149601335894
al.2173149601335681104
Molecular23011498013189147170223272330352400432
and27571498013153110170
biological2951149801316386144167225285307355405427
rationale3402149801313685118140197256305327380
of3806149801316190
hyperthermia39201498013162108168223254291349402433523545593
as4538149801315292
radio-4654149801313585145167224259
and49371498013153111170
che‑51321498013151109162197
mosensitizer8501648013190148188242299339360393416459511542
Adv14301648013165123172
Drug16261648013172104162222
Deliv18721648013171125147169218
Rev21141648013155109157
2020;23091648013153105155206224
163–164:25581648013153100151206252299355372
84–9729541648013153109166218268
16.8501796013356107130
Issels1003179601332972115170196238
RD.12641796013363136156
Hyperthermia14441798013173121182236267304362415446536558606
adds20751798013153112172211
to2310179801313793
chemotherapy24271798013152110163252311343401454486536595642
European31071798013154110141197258312360418
journal3549179801312684142173232281303
of3876179801316290
cancer39901798013153102160209260291
(Oxford,43051798013132103151183240272330348
England:46771798013154112171193242299359376
1990)50771798013157102156210237
2008;8501948013154105160214231
44(17):11051948013154110139187230259276
2546–255414051948013154107160215273320373422475
17.8502096013356103114
Maeda9872096013385138192254307
H,1317209601336890
Tsukigawa1431209601335086145195222283335414466
K,1920209601335681
Fang2024209601335098158219
J.2266209601333758
A23492098013160
Retrospective24332098013152105137169225265324377427462484533585
3030422098013149101
Years3167209801315298146177217
After3408209801316088125176207
Discovery3639209801316790128177232280332363414
of4077209801315583
the4184209801313088141
Enhanced43482098013148105162211268316367427
Permeability47992098013151101132222275322382404426447480531
and8502248013150108167
Retention10412248013155108141192250282304362420
Effect1485224801315179108160210246
of1755224801315886
Solid18652248013151109132153213
Tumors:21022248013150100189247279320338
Next‑Generation24642248013169123170207236307361419472503553585607665724
Chemotherapeutics32122248013162119172261320352410463495545604658715749771819861
and40972248013149107166
Photodynamic42872248013155112170202258319367426475564585634
Therapy‑49452248013150110163195245304351384
-Problems,850239801313389119176236259312401441459
Solutions,13332398013151110133190223245303362401420
and17772398013150107167
Prospects1968239801315586142182241295345381423
Microcirculation24342398013186108156188244294316347394451473522554576634692
(New3150239801312998151230
York,34042398013155106138184205
NY:36342398013170124138
1994)3796239801315398152206232
2016;40672398013154105153199217
23(3):43082398013154106133183208225
173–1824557239801315497149204250297348
18.8512546013356107130
Au10042546013372130
JL,1158254601334496120
Wientjes13012546013397123178239274299354397
MG.17222546013392163187
Combination19332548013167123213272295352401433455513572
intravesical2529254801312785116148198246297338359407457479
hyperthermia30322548013163109170224256293351404435525547595
and36512548013154112172
chemotherapy38472548013153111164253311344402455486536596643
for4514254801313390122
bladder4660254801316588137196256309340
cancer50242548013153103161209260292
Oncology8512698013174133181237260318379427
(Williston13022698013129122145167189210249284340398
Park)17242698013156104135181211
2010;19742698013154105153200218
26:22162698013154105122
1155–602362269801315495140188244301355
19.8512846013356106125
Inman999284601333091182234294
BA,13172846013363129154
Etienne1494284601335894119173234294349
W,18672846013397114
Rubin20052846013363123185210271
R,2299284601336388
et2410284601335996
al.2529284601335782105
The26572848013155115168
impact28492848013127116176226274310
of3184284801316291
temperature3299284801313889178237291323373405462494545
and38682848013154112172
urinary4064284801316293116174222254305
constituents43942848013153109167206241263296354407465497538
on49562848013163122
urine5102284801316293116174227
viscosity851299801315073112160216256277311362
and12372998013150108167
its142829980131235798
relevance1551299801313284106159208257315364415
to1990299801313490
bladder2104299801316184132192251304336
hyperthermia24642998013159105166220251288346399430520542590
treatment3079299801313465117165197286340398429
Int3551299801312481113
J36882998013138
Hyperthermia37502998013170118179233264301359412444533555604
2013;43972998013153105153197213
29:46342998013154105124
206–1047822998013154105160218264311
20.8513146013356111133
van10073146013351104165
der11953146013360115151
Heijden13693146013370126151177239294354
AG,17473146013365133157
Dewhirst19273146013372128208269294329373410
MW.23603146013387178196
Effects2580314801315077107159209245287
of2891314801315785
hyperthermia30003148013157103164218250287345398429519541589
in3613314801312279
neutralising37163148013157111168201233283305327366387445504
mechanisms42443148013188142191249298355377416505544
of4812314801315785
drug4922314801315889147207
resi‑5153314801313082122143176
stance851329801314176125183232282
in1158329801312380
non‑muscle‑invasive12623298013159117176209300357396445467520554578635682732772793843894
bladder2180329801316184133192252305336
cancer2540329801314999157205256288
Int2866329801312381112
J30033298013138
Hyperthermia30653298013169117178232263300358411443533555603
2016;37113298013154105153199217
32(4):39523298013154103128177203219
434–4541953298013154103157214270319
21.8513446013356107124
Franke998344601335890143204255308
K,1329344601336389
Kettering14413446013363117153192246281307367428
M,18933446013392116
Lange20323446013355110170231286
K,2341344601336489
Kaiser24533446013364117142185240276
WA,27523446013397159184
Hilger29593446013376101126188243278
I.3261344601333053
The33373448013155115168
exposure35293448013157105165224264321352403
of3957344801316290
cancer40713448013153103161209260291
cells43873448013152103126148186
to4597344801313894
hyperthermia,47153448013163109170224255292350403435525547595613
iron850359801312354110169
oxide10433598013155100122181234
nanoparticles,13013598013155104162220280330361398420468490543583601
and19263598013146104163
mitomycin21133598013187108142198287333380402459
C25963598013159
influences2679359801312077103129186239297345396436
membrane31393598013186139228288319369427480
multidrug36433598013186143165198220279310369428
resistance4095359801312980120141180215264322370421
protein4540359801315789145177228250307
expression4871359801315098158189241281321342399458
levels850374801312376125177199238
Int1132374801312381112
J12693748013137
Nanomed13313748013170119176235324378438
2013;18123748013153105153197213
8:2049374801315471
351–6321443748013154104150199256307
22.8503896013356112135
Evans10083896013352103156216259
SS,12903896013352104127
Repasky14403896013357112174228270321376
EA,18393896013352120145
Fisher2007389601335276118179234269
DT.23003896013370123139
Fever24633898013148100149200232
and27193898013147105165
the2908389801313189142
thermal3074389801313290143174264313335
regulation3433389801313082142199221270302324382440
of3898389801315684
immunity:40063898013120109198255313335368419439
the4469389801313189142
immune46353898013121110199256313367
system5026389801313887128162213302
feels850404801312981135157196
the1070404801313492145
heat12394048013159113161193
Nature14754048013170119151209240292
reviews1791404801313284133155208286327
Immunology21424048013123112201258316374397455515564
2015;27444048013153105152197212
15(6):2980404801315499124174201217
335–34932224048013153103153208256310360
23.8504196013356112134
Milani10074196013386112137189249274
V,1305419601335974
Noessner14034196013370130186229271331386422
E,1848419601335275
Ghose19464196013369130190233288
S,2257419601335275
et2355419601335289
al.246741960133517698
Heat25904198013167120168200
shock2814419801313996154204249
protein3087419801315890147179230252309
70:34214198013151101119
role3564419801313087110163
in3751419801312078
antigen38534198013147105136159218271328
presentation4205419801315991142182235293325375407429487545
and47744198013148105165
immune49634198013120109198255313366
stimulation85043480131417698186243266314346368426485
Int1378434801312381112
J15144348013138
Hyperthermia15764348013170118179233264301359412444534555604
2002;22234348013153105160210227
18(6):24744348013154100128178205221
563–57527194348013154106157212264314363
24.8504496013356108130
Arends1002449601336398152212273315
TJ,1340449601335083104
Falke1467449601334997122172224
J,1714449601333657
Lammers17944496013348101191281336371414
RJ,2231449601335598118
et2372449601335187
al.248244960133487395
Urinary2601449801316495117173222252303
cytokines2928449801314595132187232256313365405
in3356449801311976
patients34554498013157106137159211268299340
treated3819449801313061112159191241300
with4143449801317597130187
intravesical4353449801311976107139188235286325346394443465
mitomycin­48414498013186107140195284329376397454488
‑C850464801313398
with9734648013179102135193
and11904648013150108167
without13814648013180102136194252310343
hyperthermia17484648013159105166220252289347400431521543591
World23824648013191146178201260
J26664648013138
Urol27284648013169100156179
2015;29504648013153105153197212
33:31864648013154104119
1411–1733294648013154101146187236282326
25.8504796013356112133
Ware10064796013391141176230
MJ,12604796013386127149
Tinger1432479601335279139200255291
S,1746479601335274
Colbert18444796013361119145207263298337
KL,22054796013357109133
et2361479601335389
al.247347960133517699
Radiofrequency25964798013153102162184242270303354414472525582631682
treatment3302479801313163115163195284337395427
alters3753479801314770103154185226
cancer4003479801314696154202253285
cell4312479801314697120141
phenotype44774798013158117170228286318370431485
Sci5003479801314897119
Rep51464798013153106165
2015;8504948013154105153198212
5:1087494801315368
120831179494801315499150204255
26.8505096013356110132
van10055096013349102162
Valenberg11905096013358107132187247308364399459
FJP,1673509601334980138147
van18435096013349102162
der20285096013358113148
Heijden21995096013368123148173235290350
AG,25725096013363131154
Lammers27505096013348101192282337373416
RJM,3189509601335699186210
et3422509601335187
al.353350960133497496
Intravesical3653509801311977108140189236288328349397446468
radiofrequency4145509801312978137159216244277328388445497555603653
induced4822509801311977136192241291351
hy‑51975098013155100132
perthermia8505248013160113144180237289320409430477
enhances13515248013148105162210267314364404
mitomycin17785248013185106139194282328374395452
C22535248013158
accumulation2335524801314593139195283339360408439461518575
in2934524801311875
tumour3032524801313087174232289319
tissue337552480131295189128183235
Int3650524801311976107
J37815248013133
Hyperthermia38375248013165112172225256292349401432521542589
2018;44685248013149100147192209
34(7):47005248013149102130181210226
988–99349495248013149101154210261314362
27.8505396013356109121
Curley9945396013360118153179234285
SA,13025396013351116141
Palalon14665396013355107132184210270331
F,1820539601335062
Sanders19055396013351104165226281317361
KE,22895396013356111134
Koshkina24465396013356115157218269295356408
NV.28775396013369130147
The30485398013148107161
effects3233539801314978108160209246287
of3544539801315584
non‑invasive36525398013155113172205229286333383423444493545
radiofrequency4221539801312979138160218246279331391448501559607658
treatment4903539801313162114162194283336394426
and8505548013150108168
hyperthermia10425548013167113175229260298356409441531553601
on16685548013166125
malignant18175548013199148170192251309358416448
and22895548013158116176
nonmalignant24895548013168126185274323345367426484533591623
cells31365548013158109131153192
Int3372554801313189121
J35175548013146
Environ35885548013159117164187218275334
Res39465548013164117158
Public41285548013163120180203225273
Health44255548013178131180202235294
2014;47615548013162114162209225
3:5010554801316278
11(9):51125548013162103125174200217
9142–538505698013154102148197249300350
28.8505846013356111134
Lammers10075846013348102193284339374418
RJ,1448584601335699120
Witjes15915846013390115151176231274
JA,18885846013337101126
Inman2037584601332283173225286
BA,23465846013356121145
et2515584601335187
al.262558460133507597
The27465848013147107160
role2930584801312885108160
of3114584801315583
a32215848013146
combined32915848013145101190250272330382442
regimen3757584801312980140162250303361
with4142584801317598131189
intravesical4355584801311976108140189237288328350398447469
chemothe‑48485848013145103156244303335393445481
rapy850599801313282142189
and10635998013150108167
hyperthermia12555998013159105166220251288346399431520542591
in1870599801312380
the1974599801313493146
management21445998013190139197245305358447500558590
of2758599801315887
non28695998013159117176
muscle30695998013190147186235257310
invasive3403599801312381128178217239288340
bladder3767599801316184132192251304336
cancer:4127599801314999156205256287307
A44585998013165
systematic4547599801314190131165216305354386408457
review5028599801313284133155208286
Eur8506148013151107138
Urol10126148013169100156179
2011;12346148013153105153193204
60:14626148013154108126
81–9316126148013154102151204253
29.8506296013356110128
Brummelhuis1001629601335590150240330384410469528552594
ISG,1618629601332274144167
Wimper18086296013389114204265320355
Y,2186629601335569
Witjes‑van22786296013389114150174228271303355407466
Os27676296013371114
HGJM,29046296013367137178265288
et3215629601335187
al.332462960133497496
Long‑Term34446298013145101158217249293339369458
Experience3926629801314795154208238261312369417467
with4417629801317597129186
Radiofrequency­46276298013151100159180237265297348407463515572620670702
‑Induced850644801313358117178236286338399
Hyperthermia12746448013179128190245277315375429461553575625
Combined19236448013172130221282305364418480
with24276448013189113147206
Intravesical2658644801313291123156207256309350372421472495
Chemotherapy31786448013171130184275335368427482514565626674
for3877644801313796128
Non‑Muscle40306448013180139199234322381421471494548
Invasive4602644801313291139190231253303356
Bladder4983644801316588138199259313346
Cancer8506598013163112170219270301
Cancers11896598013163113170219270301342
2021;15756598013154105155202212
13:1811659801315499114
37719496598013154102155
30.8516746013356112133
Colombo10086746013360119145205297359420
R,1451674601335681
Da15556746013370123
Pozzo17016746013355113159209268
LF,19936746013349101113
Lev21296746013349104155
A,2308674601336489
et2420674601335288
al.253267460133507598
Local26536748013146103152202224
microwave29016748013187109157189245324373421473
hyperthermia33986748013156102162216248285343396427517539587
and40106748013146104163
intravesical4198674801311977109140190238290330351400449472
chemotherapy46946748013145103156245304336394447479529588635
as851689801315090
bladder965689801316184132192251304336
sparing13256898013141100150181204261321
treatment1670689801313466117165197287340398430
for2124689801312986118
selected2266689801314194117170219255306366
multifocal26576898013190147169202224253310359409431
and31126898013150108168
unresectable33046898013158116147199239292341378427487510563
superficial3891689801314197157211242272299347369417439
bladder4354689801316184133192252305336
tumors4714689801313492181239271312
J50706898013138
Urol51326898013169100156179
1998;851704801315499152205222
159:1098704801315398147165
783–712877048013154104156211258
31.8507196013356106123
Brisuda997719601335691117159219281333
A,1353719601336489
Babjuk14657196013356109171197257308
M,17967196013385109
Stolz1928719601335185144170216
J.2168719601333758
Intravezikální2251719801312077109141191238290335357403453476533555
chemoterapie28307198013145103156245303336387418468528550603
s34577198013137
využitím3518719801314698157201223257279367
tepelné3910719801313081141195217275328
energie42627198013149107160192250272324
u46107198013155
pacientů46897198013157107156177230288320377
s50907198013138
uro‑5152719801315586142177
teliálním850734801313485108129177200257279367
karcinomem1242734801314697128175197254312402455544
močového18107348013190149198254302354412470
měchýře23047348013190143193250297329380
bez27087348013161115160
invaze2892734801312380128177222273
svaloviny3190734801314191141163221269292350396
Ces36237348013163114154
Urol38017348013169100156180
2017;40237348013154105153197210
21(2):42577348013154101122173199216
122–1284497734801315498151203249293344